- CH₣892.19m
- CH₣721.85m
- €104.17m
Europe Research Roundup: A.P. Moller-Maersk, Beiersdorf AG, Hammerson
Europe Research Roundup: BP, Fresenius, Innogy
Brief: Cosmo Pharmaceuticals H1 Loss Of EUR 20.8 Million
Brief: Cosmo Pharmaceuticals: Canadian Agency Approval Of Eleview
Brief: Cosmo Pharmaceuticals Announces Publication Of Positive Review Of Aemcolo
Live Markets: What's on the radar: German cars, Swiss pharma, Ted Baker
Swiss stocks - Factors to watch on June 11
Brief: FDA Accepts NDA Filing For Cosmo Pharmaceuticals' Remimazolam
Europe Research Roundup: Acerinox, FirstGroup, Hochtief
Swiss stocks - Factors to watch on May 8
Brief: Cosmo Pharmaceuticals Announces Distribution Agreement And Further Collaboration Agreement
Brief: Cosmo Pharmaceuticals: FDA Allowance Of IND Application For CB-03-10
Europe Research Roundup: Acacia Mining, Boliden, Cosmo Pharmaceuticals
Brief: Cosmo Pharmaceuticals: Worldwide Distribution Agreement Of AI Device In Colonoscopy With Medtronic
Brief: Cosmo Pharmaceuticals Announces Submission Of Remimazolam NDA To FDA
Brief: Cosmo Pharmaceuticals FY Oper Loss Widens To EUR 16.6 Mln
Swiss stocks - Factors to watch on March 29
Cosmo Pharmaceuticals sinks after FDA denies Methylene Blue appeal
Brief: Cosmo Pharmaceuticals Announces Denial Of Methylene Blue MMX Appeal